[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"av-node-ablation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:av-node-ablation":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100611789",false,"NCT07245147","REDO-AF: Randomized Evaluation of Dual Options for AF Re-intervention","REDO-AF","Inclusion Criteria:\n\n* One or more prior left atrial (LA) ablation procedure(s) for AF\n* Symptomatic AF\u002Fatypical atrial flutter\u002Fatrial tachycardia with failure of or intolerance to medical rate or rhythm control therapy, that is detected at \\>2 months post most recent LA ablation procedure\n* Either a LA volume index on any prior echo of \\>= 45ml\u002Fm2 or LA diameter \\>= 50mm OR a HATCH score \\>=2 (where 1 point is given for each for hypertension, Age\\>75, COPD, and 2 points for each of stroke\u002FTIA, or HF (defined as signs or symptoms of pulmonary edema and may include HFrEF or HFpEF)\n* Be considered suitable for both treatment strategies of redo ablation and pacemaker and AV node ablation\n* Willingness to participate, complete the QOL questionnaires and ability to sign informed consent\n\nExclusion Criteria:\n\n* Severe valvular disease defined by echo criteria\n* Myocardial infarction, stroke, or coronary revascularization within the previous 3 months\n* LVEF \\\u003C40% or need for an ICD\n* Life expectancy \\\u003C24 months\n* Lack of capacity to consent","ALL","18 Years",{"count":18,"type":19},16,"ESTIMATED","INTERVENTIONAL",[22],"NA","The goal of this randomized open-label clinical trial is to evaluate two different strategies for the treatment of recurrent atrial fibrillation (AF) after AF ablation. Patients who have symptomatic, drug-refractory recurrence of AF will be randomized to either a redo AF ablation vs conduction system pacing with AV node ablation. Patients will need to have undergone at least 1 prior AF ablation to be considered eligible for the study. The current trial is a vanguard study of 16 patients and will determine the feasibility of enrolment, compare changes in quality of life, and inform the design of the definitive REDO AF trial.",[25,26,27],"Atrial Fibrillation (AF)","AV Node Ablation","Left Bundle Branch Pacing",[29,30,31,32,33,34],"Atrial fibrillation","pace and ablate","AV node ablation","Left bundle branch pacing","LBBP","Redo","NOT_YET_RECRUITING","2025-11-20",{"date":38,"type":39},"2025-11-24","ACTUAL",{"date":41,"type":19},"2025-11",{"date":43,"type":19},"2027-09",{"name":45,"class":46},"Jacqueline Joza","OTHER",""]